Esthesioneuroblastoma natural history, complications and prognosis: Difference between revisions
Simrat Sarai (talk | contribs) No edit summary |
Simrat Sarai (talk | contribs) |
||
Line 7: | Line 7: | ||
==Complications== | ==Complications== | ||
==Prognosis== | ==Prognosis== | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center | |||
|valign=top| | |||
|+ | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Grade of the tumor}} | |||
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Ten-year survival}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | |||
:Grade I and II tumors | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*67% | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | |||
:High-grade lesions (III and IV) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*34% | |||
|- | |||
|} | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center | |||
|valign=top| | |||
|+ | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Grade of the tumor}} | |||
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Five-year survival}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | |||
:Low-grade lesions (Hyams I and II) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*56% | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | |||
:High-grade lesions (Hyams III and IV) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*20% | |||
|- | |||
|} | |||
Treatment usually involves combined chemotherapy and/or radiotherapy with surgical excision. Prognosis is significantly affected by presence of distant metastases. | Treatment usually involves combined chemotherapy and/or radiotherapy with surgical excision. Prognosis is significantly affected by presence of distant metastases. | ||
Line 33: | Line 68: | ||
|- | |- | ||
|} | |} | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 05:47, 26 January 2016
Esthesioneuroblastoma Microchapters | |
Diagnosis | |
---|---|
Treatment | |
Case Studies | |
Esthesioneuroblastoma natural history, complications and prognosis On the Web | |
American Roentgen Ray Society Images of Esthesioneuroblastoma natural history, complications and prognosis | |
FDA on Esthesioneuroblastoma natural history, complications and prognosis | |
CDC on Esthesioneuroblastoma natural history, complications and prognosis | |
Esthesioneuroblastoma natural history, complications and prognosis in the news | |
Blogs on Esthesioneuroblastoma natural history, complications and prognosis | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
Natural History
Clinical presentation is usually secondary to nasal stuffiness and rhinorrhoea or epistaxis. Presentation is often delayed and symptoms may have been present for many months. Patients often present late with larger tumours which can extend into the intracranial compartment (25-30% at diagnosis) and usually result in anosmia.
Complications
Prognosis
Grade of the tumor | Ten-year survival |
---|---|
|
|
|
|
Grade of the tumor | Five-year survival |
---|---|
|
|
|
|
Treatment usually involves combined chemotherapy and/or radiotherapy with surgical excision. Prognosis is significantly affected by presence of distant metastases.
Metastasis | Five-year survival |
---|---|
|
|
|
|
|
|